New 78XXX Series CPT® Codes Replace HCPCS G Codes for PET Procedures


As of April 18, 2005, the Centers for Medicare and Medicaid Services (CMS) will no longer accept the Healthcare Common Procedure Coding System (HCPCS) G codes for the reporting of positron emission tomography (PET) procedures that are covered nationally; they will be replaced with the 78XXX series CPT® codes (CMS Transmittal #527, CR 3741, April 15, 2005). The 78XXX series CPT® codes can be used to report PET retroactively to January 28, 2005.

PET claims submitted with a G code after April 18, 2005, will not be paid. Note that these dates supersede the effective date of January 1, 2005, and the implementation date of April 4, 2005, as was stated in CMS Transmittal #475, CR3726, February 11, 2005. Transmittal #518, April 8, 2005, has been rescinded.

CMS activated 11 PET CPT® codes: 3 cardiac (78459, 78491, 78492), 2 brain (78608, 78609), and 6 new tumor (78811-78816). The table below lists a crosswalk from the inactivated G codes to the new CPT®. All HCPCS Level II G codes have a status indicator "I", which is defined by CMS as, "Not valid for Medicare purposes. Medicare uses another code for the reporting of, and the payment for these codes."

Table 1
PET CPT® Codes Effective 1/28/05 CPT® Description of PET Procedure Inactivated HCPCS Codes as of April 18, 2005 Professional Component1

Status            Total RVUs

Technical
Component

Status

Global

Status

78459 Myocardial imaging, PET, metabolic evaluation G0230 A 2.12 C C
78491 Myocardial imaging, PET, perfusion; single study at rest or stress G0030, G0032, G0034, G0036, G0038, G0040, G0042, G0044, G0046 A 2.15 C C
78492 Myocardial imaging, PET, perfusion; multiple studies at rest and/or stress G0031, G0033, G0035, G0037, G0039, G0041, G0043, G0045, G0047 A 2.68 C C
78608 Brain imaging, PET, metabolic evaluation G0229, G0336 A 2.07
(+2.07)
C C
78609 Brain imaging, PET, perfusion evaluation There are no G codes for PET imaging for brain perfusion evaluation. A 2.07

(+2.07)

C C
78811 Tumor imaging, PET, limited area (e.g., chest, head/neck) G0125, G0219, G0210- G0218, G0220- G0228, G0253, G0254, G0296 A 2.18

(+.53)

C C
78812 Tumor imaging, PET; skull base to mid-thigh G0125, G0219, G0210- G0218, G0220- G0228, G0253, G0254, G0296 A 2.70

(+.66)

C C
78813 Tumor imaging, PET; whole body G0125, G0219, G0210- G0218, G0220- G0228, G0253, G0254, G0296 A 2.80

(+.69)

C C
78814 Tumor imaging, PET with concurrently acquired CT for attenuation correction and anatomical localization; limited area (e.g., chest, head/neck) N/A A 3.07

(+.76)

C C
78815 Tumor imaging, PET with concurrently acquired CT for attenuation correction and anatomical localization; skull to mid-thigh N/A A 3.39

(+.84)

C C
78816 Tumor imaging, PET with concurrently acquired CT for attenuation correction and anatomical localization; whole body N/A A 3.47

(+.86)

C C

"A" = Active status
"C" = Carrier Priced
"N/A" = Not available

1Relative Value Units (RVUs) per Pub 100-04, Medical Claims Processing, Transmittal #475, CR 3726,
February 11, 2005, First Update to the 2005 Medicare Physician Fee Schedule Database.

The following G codes are excluded (E) from payment or deleted (D) by Medicare.

Table 2
Code Status Description
G0219 E PET imaging whole body; melanoma for non-covered indications
G0235
(effective 1/28/05)
E PET Imaging, any site, not otherwise specified (non-covered service)
G0252 E PET imaging, full/partial-ring PET scanner only, for initial diagnosis of breast cancer and/or surgical planning for breast cancer, not covered
G0330 D
(effective 10/01/04)
PET imaging, initial diagnosis cervical
G0331 D
(effective 10/01/04)
PET imaging restage ovarian cancer

"E" = service is excluded from the Medicare Physician Fee Schedule
"D" = deleted from Medicare (See Medlearn Matters # MM3750)

PET imaging codes G0219 (whole body; melanoma for noncovered indications), G0235 (any site, not otherwise specified), and G0252 (initial diagnosis of breast cancer and/or surgical planning for breast cancer) have been labeled with an "E" status indicator, indicating they are excluded from the physician fee schedule by regulation and are not covered by Medicare.

Reimbursement

As listed in the First Update to the 2005 Medicare Physician Fee Schedule (Transmittal 475, CR 3726, February 11, 2005) and as noted in Table1 above, the professional component relative value units (RVUs) for the myocardial PET studies have remained the same. However, PET brain imaging studies which were previously valued in the fee schedule as 0 now have a total professional RVU value of 2.07, and the remainder of the PET studies show an increase due to an increase in the practice expense. Note that the technical and global components continue to be carrier-priced. Carriers will establish payment amounts for the technical and global components, generally on a case-by-case basis, following review of documentation. The ACR is assisting Carrier Advisory Committee network representatives on this issue.

PET Coverage for Various Cancers and "Coverage with Evidence Development"

The Centers for Medicare and Medicaid Services (CMS) issued an update on April 1, 2005, to the National Coverage Determination (NCD) on PET for brain, cervical, ovarian, pancreatic, small-cell lung, and testicular cancers (Pub. 100-03, Transmittal 31, CR 3741). Initially, CMS implemented limited PET coverage for certain cancers; however, this PET coverage was expanded by CMS for all oncology indications with a requirement that physicians participate in and patients be enrolled in an approved clinical trial or registry. This PET NCD update clarifies the types of cancers that are covered and the clinical trials/registry enrollment requirement. All covered PET services specified in the NCD that were performed between January 28, 2005, and April 17, 2005, may be submitted retroactively as per Transmittal #527, CR 3741 (Transmittal #518 rescinded). Note that the current dates listed supersede the dates listed in Transmittal #475, CR 3726.

CMS will notify Medicare providers and beneficiaries through the Federal Registry Notice and CMS coverage Web site at www.cms.gov/coverage as more details develop and become available on PET coverage with evidence development. In addition, CMS intends to release through these venues additional clinical study/registry enrollment process information. The ACR does not anticipate that guidelines and enrollment for the PET registry will be ready until later this summer. For more details regarding the recent CMS NCD PET update, please refer to CMS Transmittal 31, CR 3741 at http://www.cms.hhs.gov/manuals/pm_trans/R31NCD.pdf

Links:

CMS Transmittal 527, CR 3741, April 15, 2005
http://www.cms.hhs.gov/manuals/pm_trans/R527CP.pdf

Transmittal 518, CR 3741, April 1, 2005 - RESINCDED
http://www.cms.hhs.gov/manuals/pm_trans/R518CP.pdf

CMS Transmittal 475, CR3726, February 11, 2005
http://www.cms.hhs.gov/manuals/pm_trans/R475CP.pdf

Federal Register Vol. 69, No. 216, November 15, 2004, p 66427
http://a257.g.akamaitech.net/7/257/2422/15nov20040800/edocket.access.gpo.gov/2004/pdf/04-24758.pdf

Society of Nuclear Medicine, PET C&R Educational Materials, March 2005
http://interactive.snm.org/index.cfm?PageID=1110&RPID=3854&FileID=19826

CMS Transmittal 402, CR 3621, December 17, 2004
http://www.cms.hhs.gov/manuals/pm_trans/R402CP.pdf
http://www.cms.hhs.gov/medlearn/matters/mmarticles/2005/MM3750.pdf

CMS Transmittal 31, CR 3741
http://www.cms.hhs.gov/manuals/pm_trans/R31NCD.pdf

Medicare National Coverage Determinations (NCD) Manual
Publication 100-03, Section 220.6
http://www.cms.hhs.gov/manuals/103_cov_determ/ncd103c1_Part4.pdf